Please use this identifier to cite or link to this item:
Title: Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study
Filiation: Servicio de Farmacia. Hospital Universitario de Fuenlabrada
Issue Date: 8-Apr-2021
Citation: BMC Health Serv Res.2021 Apr;(21)1:320
Abstract: Subcutaneous (SC) versus intravenous (IV) administration is advantageous in terms of patient convenience and hospital efficiency. This study aimed to compare the effect of optimizing the processes involved in SC versus IV administration of rituximab and trastuzumab on hospital capacity and service quality.
PMID: 33832464
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
BMC Health Services Research.pdf964.44 kBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons